A liquid chromatographic method using electrochemical detection is presented for measuring the thiol WR-1065 [2-(3-aminopropylamino) ethanethiol] and its symmetrical disulfide WR-33278 [NH 2 (CH 2 ) 3 NHCH 2 CH 2 S] 2 . WR-1065 is the active, radioprotective drug derived from the phosphorothioate pro-drug WR-2721 (amifostine). External standard curves for both compounds were linear over the range of 40-200 pmol injected (r 2 = 0.999 and 0.996 for the thiol and disulfide, respectively). The detection and quantitation limits for WR-1065 were 9 and 18 pmol, respectively, whereas the corresponding values for WR-33278 were 30 and 59 pmol, respectively. Within-and between-day determinations of measurement precision and accuracy for both compounds validated the suitability of this assay method.
Summary of Results of Verification Study

Submitting Laboratory
(1.1.1) Matrixes.-This method demonstrates the external standard calibration for WR-1065 and WR-33278 prepared from pure standards obtained from the National Cancer Institute (Bethesda, MD).
(1.1.2) Study design.-Recovery, precision, and reproducibility were determined from 5 spiked samples over 3 concentration ranges over 7 days for both compounds. A summary of the measurement of within-and between-day precision and accuracy is shown in Table 1 .
Peer Laboratory
(1.2.1) Matrixes.-Pure standards of WR-1065 and WR-33278 in a stock concentration of 3mM in 0.01N HCl were prepared by weighing 0.621 and 1.386 g/100 mL, respectively.
(1.2.2) Study design.-Determination of the accuracy and precision of the external standard calibration for both compounds was made at 3 concentration levels over 7 days. The data are summarized in Table 2 .
Recovery
(1.3.1) Accuracy.-The accuracy of the method was determined by recovery of added analyte over 3 concentration ranges, as described by the AOAC Peer-Verified Methods Program Manual on Policies and Procedures (1). Recovery is expressed as the amount of the compound detected as a percentage of the theoretical amount injected into the column. Recovery averaged 100% for both the thiol and the disulfide.
(1.3.2) Precision.-The relative standard deviation (RSD) of the method averaged 1.75% for thiols and 3.05% for disulfides.
Standard Curve
External calibration curves, prepared for the analysis of thiol and disulfide samples, were linear over the concentration range of 40-200 pmol/injection. The equations of the linear calibration curves were y = 715.39x -11511 (r 2 = 0.999) for WR-1065 and y = 443.77x = 1876.4 (r 2 = 0.996) for WR-33278.
Limit of Detection
The limits of detection (LOD) were 0.45 µmol/L (9 pmol/20 µL injected) for the thiol and 1.5 µmol/L (30 pmol/20 µL injected) for the disulfide. LOD is defined as 3.3 standard deviations of the response divided by the slope of the calibration curve (1).
Limit of Quantitation
The limits of quantitation (LOQ) were 0.9 µmol/L (18 pmol/20 µL injected) for the thiol and 2.95 µmol/L (59 pmol/20 µL injected) for the disulfide. LOQ is defined as 10 standard deviations of the response divided by the slope of the calibration curve (1).
Safety Precautions
Normal laboratory safety precautions should be observed at all times. In particular, mercury should be kept in clearly labeled, tightly closed, and, if possible, unbreakable containers. These primary mercury containers should then be kept in spill-proof secondary containers. Use minimum quantities of mercury, consistent with operational requirements.
Scope
A method is described for the determination of WR-1065 and WR-33278 by liquid chromatography with electrochemical detection (LC-ECD) and the use of external standard calibration. WR-1065 is a radioprotective aminothiol drug, and WR-33278 is the symmetrical disulfide. Both are metabolites of the cytoprotective pro-drug amifostine [WR-2721; S-2-(3-aminopropylamino) ethylphosphorothioate]. Although WR-2721 is an excellent radioprotective drug, its use is limited because of its toxicity (2). One approach to limiting the toxicity is to slow down its release into the bloodstream. 
Principle
LC-ECD (5, 6) is used for the chromatographic separation and simultaneous determination of thiols and disulfides. The electrochemical detector consists of dual thin-layer gold-mercury amalgam electrodes operated in series. Disulfides are first converted to thiols at the upstream, generator electrode set at -1 V vs Ag/AgCl. Thiols and reduced disulfides are detected downstream, at the working electrode set at +0.15 V, where they are catalytically oxidized. Only the downstream, working electrode is monitored. The high selectivity of the Hg surface-specific detector reaction at the working electrode ensures a low probability of interference. To improve the chromatography of the thiol, a trace amount of 2-mercaptoethylamine (cysteamine) is added to the mobile phase (7). Because cysteamine acts as a competitive ion for reactive species found on the reversed-phase column, the addition of cysteamine to the mobile phase improves thiol peak shape and thus thiol detectability.
Standard Solutions
External standard solutions.-The equivalent of 10mM WR-1065 (FW = 207, based on C 5 H 14 N 2 S⋅2HCl) and the equivalent of 10mM WR-33278 (FW = 462, based on C 10 H 26 N 4 S 2 ⋅H 6 P 2 O 8 ) were weighed and dissolved in 0.01N HCl. The stock solutions were separated into 25 µL aliquots, stored at -20°C, and serially diluted with the mobile phase as needed for calibration curves. To minimize the effects that multiple cycles of freezing and thawing would have on the composition of the compounds, an aliquot of frozen stock solution was thawed and used only once to prepare calibration curves.
7 Reagents (7.1.1) Monochloroacetic acid.-99.8% (Sigma, St. Louis, MO).
(7.1.2) Hexanesulfonic acid.-Sodium salt, monohydrate (Fluka, Buchs, Switzerland).
(7.1.3) Acetonitrile.-99.9+%, LC grade (Sigma-Aldrich, St. Louis, MO).
(7.1.4) 2-Mercaptoethylamine (cysteamine).-Hydrochloride form (Sigma).
(7.1.5) Water.-Deionized with reversed osmosis to 18 mS.
(7.1.6) Helium.-Compressed gas, ultrahigh purity, 99.999%. 9 Procedure (9.1.1) Sample preparation.-Pure standards of WR-1065 and WR-33278 in a stock concentration of 10mM in 0.01N HCl were prepared by weighing 0.207 and 0.462 g/100 mL, respectively. The standard stock solutions were serially diluted with the mobile phase so that 5 calibration solutions, each with thiol and disulfide at 40, 60, 100, 160, and 200 pmol/20 µL were prepared for construction of calibration curves and recovery determinations.
(9.1.2) Chromatography.-The full-scale sensitivity of the detector (working electrode) was programmed to 50 nA for all measurements. Separated chromatographically from the thiol, the disulfide is reduced to thiol at the upstream, generator electrode and is detected as a thiol downstream at the detector electrode. The mobile phase is run isocratically and after system equilibration, 20 µL of each standard sample containing both compounds is injected into the column, and a standard curve is prepared for both the thiol and the disulfide. Recoveries were determined by injecting 5 replicates of 20 µL each at 60, 100, and 160 pmol.
(9.1.3) Calculations.-By using an external standard calibration method in the ChromPerfect Magellan data reduction software, linear standard curves were produced (r 2 ≥ 0.995) for both the thiol and the disulfide compounds. Based on the thiol and disulfide external standard calibration curves, recovery was expressed as the amount of the compound detected as a percentage of the theoretical amount injected into the column. The accuracy of the determinations measured how close the 5 replicate detected values came to the true, injected amount of compound. Precision was determined by how close the detected data values were to each other over the 5 replicate injections.
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